Trial Profile
ZO-Y49 PhaseIII clinical trial
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 May 2016
Price :
$35
*
At a glance
- Drugs ZO Y49 (Primary)
- Indications Female genital diseases
- Focus Adverse reactions; Therapeutic Use
- Sponsors Zeria
- 26 May 2016 New trial record